Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 1.1. It has been cited 33 times, with 32 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.529
From this paper's citation signal
Citation Network Contribution
0.546
From 26 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 32 citers.
National Institutes of Health
Grant: R21AI143227
National Institutes of Health
Grant: 5T32AI106677-07 (T32)
National Institutes of Health
Grant: 1F32AI145283-01A1 (F32)
NIAID NIH HHS
Grant: F32 AI145283
NIAID NIH HHS
Grant: T32 AI106677
National Institutes of Health
Grant: 1F32AI145283-01A1
Regulatory T cells impose specific translatome changes in effector CD4 T cells
National Institutes of Health
Grant: 5T32AI106677-07
Basic Training at the Intersection of Innate and Adaptive Immunity in Disease
National Institutes of Health
Grant: 5R21AI143227-02
Translational Reprogramming by Regulatory T Cells
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals